TrialJournal of cancer research and clinical oncology2023

Do patients with metastatic renal cell carcinoma obtain survival benefits from cytoreductive nephrectomy? A population-based study.

Zhenkai Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.